These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1478421)

  • 1. [4-ASA by oral administration in hemorrhagic rectocolitis: first controlled study].
    Lémann M
    Gastroenterol Clin Biol; 1992; 16(10):827-8. PubMed ID: 1478421
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical salicylate therapy (4-ASA and 5-ASA enemas).
    Ginsberg AL
    Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The place of oral 5-aminosalicylic acid in the therapy of ulcerative colitis.
    Meyers S
    Am J Gastroenterol; 1988 Jan; 83(1):64-7. PubMed ID: 3337061
    [No Abstract]   [Full Text] [Related]  

  • 4. Does rectal sparing ever occur in ulcerative colitis?
    Glickman JN; Odze RD
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S166-7. PubMed ID: 18816786
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral 4-aminosalicylic acid therapy in ulcerative colitis.
    Gaffney P; Doyle C; Gaffney A
    Gastroenterology; 1992 Nov; 103(5):1706-7. PubMed ID: 1426895
    [No Abstract]   [Full Text] [Related]  

  • 6. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
    Marshall JK; Irvine EJ
    Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New treatments of hemorrhagic rectocolitis].
    Rambaud JC
    Ann Gastroenterol Hepatol (Paris); 1988; 24(4):173-7. PubMed ID: 2901821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course.
    Habal FM; Hui G; Greenberg GR
    Gastroenterology; 1993 Oct; 105(4):1057-60. PubMed ID: 8405849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral 4-ASA in ulcerative colitis.
    Lahoti D; Broor SL
    Indian J Gastroenterol; 1992 Oct; 11(4):184-5. PubMed ID: 1398800
    [No Abstract]   [Full Text] [Related]  

  • 10. Sulfasalazine and new analogues.
    Friedman G
    Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral 5-ASA therapy in ulcerative colitis: what are the implications of the new formulations?
    Sandborn WJ
    J Clin Gastroenterol; 2008 Apr; 42(4):338-44. PubMed ID: 18277908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
    Andreoli A; Spinella S; Levenstein S; Prantera C
    Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and tolerability of 5-aminosalicylic acid in the short-term treatment of ulcerative rectocolitis during the mild or moderate stage].
    Bresci G; Carrai M; Venturini G; Gambardella L
    Minerva Dietol Gastroenterol; 1990; 36(1):31-3. PubMed ID: 1970855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone.
    D'Arienzo A; Manguso F; Castiglione GN; Vicinanza G; Scaglione G; Bennato R; Sanges M; Mazzacca G
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):254-7. PubMed ID: 9759590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.
    Mantzaris GJ; Archavlis E; Christoforidis P; Kourtessas D; Amberiadis P; Florakis N; Petraki K; Spiliadi C; Triantafyllou G
    Am J Gastroenterol; 1997 Mar; 92(3):454-6. PubMed ID: 9068468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are there reliable predictive factors of nonresponse to aminosalicylates in patients with ulcerative colitis?
    Gisbert JP; Chaparro M
    United European Gastroenterol J; 2019 Oct; 7(8):997-998. PubMed ID: 31662857
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ulcerative colitis. Maintenance therapy].
    Kruis W; Schreiber S
    Z Gastroenterol; 2004 Sep; 42(9):1011-4. PubMed ID: 15455275
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study.
    d'Albasio G; Pacini F; Camarri E; Messori A; Trallori G; Bonanomi AG; Bardazzi G; Milla M; Ferrero S; Biagini M; Quaranta S; Amorosi A
    Am J Gastroenterol; 1997 Jul; 92(7):1143-7. PubMed ID: 9219787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: induction therapy for patients with active ulcerative colitis.
    Travis SP
    Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 1():10-6. PubMed ID: 16939424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent versus continuous 5-aminosalicylic acid treatment for maintaining remission in ulcerative colitis.
    Bardazzi G; d'Albasio G; Bonanomi AG; Trallori G; Messori A; Amorosi A; Bartoletti L; Morettini A; Pacini F
    Ital J Gastroenterol; 1994 Sep; 26(7):334-7. PubMed ID: 7812025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.